Synthetic
retinoid agonist. Antiproliferative, antioxidant and anticancer agent with a
long half-life in vivo. Apoptotic effects appear to be mediated by a mechanism
distinct from that of 'classical' retinoids.
Ulukaya
and Wood (1999)
Fenretinide and its relation to cancer. Cancer Treat.Rev. 25 229.
Takahashi (2000) Antioxidant properties of N-(4-hydroxyphenyl)retinamide
(fenretinide). Biol.Pharm.Bull. 23 222. Le Dozeet al
(2000) Pharmacokinetics of all-trans retinoic acid, 13-cis retinoic acid, and
fenretinide in plasma and brain of rat. Drug Metab.Disp. 28 205.